RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Allen, TX · Amarillo, TX · +44 more sites
Clinical trials in Katy, TX
19 recruiting studies have a site in or near Katy, TX, Texas.
Top conditions here
- Rheumatoid Arthritis (4)
- Type 2 Diabetes (3)
- Depression (2)
- Alzheimer's Disease (2)
- COPD (2)
- Lupus (2)
- Type 1 Diabetes (2)
- Obesity (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 19 of 19 studies
RecruitingPhase 3NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Sponsor: Hoffmann-La Roche
Beaumont, TX · Brownsville, TX · Dallas, TX · +65 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Allen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
El Paso, TX · Georgetown, TX · Houston, TX · +98 more sites
RecruitingPhase 2NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Sponsor: Boehringer Ingelheim
Amarillo, TX · Colleyville, TX · Euless, TX · +27 more sites
RecruitingPhase 3NCT06307652
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Sponsor: AstraZeneca
Allen, TX · Amarillo, TX · +163 more sites
RecruitingPhase 2NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Sponsor: AbbVie
Austin, TX · Carrollton, TX · Corpus Christi, TX · +46 more sites
RecruitingPhase 3NCT07775300
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Sponsor: Eli Lilly and Company
Austin, TX · Beaumont, TX · DeSoto, TX · +31 more sites
RecruitingPhase 2NCT07284667
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Sponsor: ACADIA Pharmaceuticals Inc.
Houston, TX · Katy, TX · +25 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Abilene, TX · Amarillo, TX · Austin, TX · +232 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · +96 more sites
RecruitingPhase 3NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Sponsor: Janssen Research & Development, LLC
Amarillo, TX · Frisco, TX · +35 more sites
RecruitingPhase 4NCT07633470
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Sponsor: Alpha Cognition, Inc
Katy, TX · +19 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Dallas, TX · Houston, TX · +61 more sites
RecruitingPhase 3NCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Conroe, TX · +106 more sites
RecruitingPhase 2NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Sponsor: Artiva Biotherapeutics, Inc.
Arlington, TX · Bellaire, TX · Irving, TX · +28 more sites
RecruitingPhase 3NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sponsor: GlaxoSmithKline
Dallas, TX · DeSoto, TX · Greenville, TX · +39 more sites
RecruitingPhase 3NCT06747949
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sponsor: Amgen
Baytown, TX · Colleyville, TX · Katy, TX · +28 more sites
RecruitingPhase 4NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Sponsor: Brigham and Women's Hospital
Katy, TX · McKinney, TX · +34 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.